The revenue in the 'Digestives & Intestinal Remedies' segment of the OTC pharmaceuticals market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 111.7 million U.S. dollars (+33.78 percent). After the ninth consecutive increasing year, the indicator is estimated to reach 442.35 million U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Digestives & Intestinal Remedies' segment of the OTC pharmaceuticals market was continuously increasing over the past years.
Data provided by Statista Market Insights are estimates.
Definition: The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information: The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included. For more information on the data displayed, use the info button next to the boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (April 8, 2024). Revenue of the digestive and intestinal remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars) [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue
Statista. "Revenue of the digestive and intestinal remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars)." Chart. April 8, 2024. Statista. Accessed November 23, 2024. https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue
Statista. (2024). Revenue of the digestive and intestinal remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue
Statista. "Revenue of The Digestive and Intestinal Remedies Market in Indonesia from 2020 to 2029 (in Million U.S. Dollars)." Statista, Statista Inc., 8 Apr 2024, https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue
Statista, Revenue of the digestive and intestinal remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue (last visited November 23, 2024)
Revenue of the digestive and intestinal remedies market in Indonesia from 2020 to 2029 (in million U.S. dollars) [Graph], Statista, April 8, 2024. [Online]. Available: https://www.statista.com/forecasts/1400503/indonesia-digestive-and-intestinal-remedies-market-revenue
